Showing 1 to 12 of 13 results


New Barbie Doll Features Type 1 Diabetes
Mattel released a new Barbie doll with type 1 diabetes, including accessories like a continuous glucose monitor and insulin pump, in collaboration with Breakthrough T1D to increase representation and understanding of the condition.
New Barbie Doll Features Type 1 Diabetes
Mattel released a new Barbie doll with type 1 diabetes, including accessories like a continuous glucose monitor and insulin pump, in collaboration with Breakthrough T1D to increase representation and understanding of the condition.
Progress
20% Bias Score


Mattel's New Barbie Doll Raises Awareness for Type 1 Diabetes
Mattel launched a new Barbie doll with type 1 diabetes, featuring an insulin pump and continuous glucose monitor, at the Breakthrough T1D Children's Congress; this is part of an advocacy effort to renew funding for the Special Diabetes Program and increase awareness of the roughly 304,000 children a...
Mattel's New Barbie Doll Raises Awareness for Type 1 Diabetes
Mattel launched a new Barbie doll with type 1 diabetes, featuring an insulin pump and continuous glucose monitor, at the Breakthrough T1D Children's Congress; this is part of an advocacy effort to renew funding for the Special Diabetes Program and increase awareness of the roughly 304,000 children a...
Progress
36% Bias Score


Lab-Grown Cells Cure Complex Type 1 Diabetes in Clinical Trial
Lab-grown insulin-producing cells successfully cured complex type 1 diabetes in a clinical trial, potentially solving donor shortages and offering a cure for approximately 120,000 patients in the Netherlands, with a new research center in Leiden focusing on broader implementation.
Lab-Grown Cells Cure Complex Type 1 Diabetes in Clinical Trial
Lab-grown insulin-producing cells successfully cured complex type 1 diabetes in a clinical trial, potentially solving donor shortages and offering a cure for approximately 120,000 patients in the Netherlands, with a new research center in Leiden focusing on broader implementation.
Progress
40% Bias Score


Type 1 Diabetes in Children: High Prevalence of Co-occurring Autoimmune Diseases and Mental Health Challenges
A study presented at the Spanish Diabetes Society congress reveals that children with type 1 diabetes frequently develop other autoimmune diseases like celiac disease and thyroid disorders, significantly increasing the complexity of care and impacting mental health; interventions like summer camps a...
Type 1 Diabetes in Children: High Prevalence of Co-occurring Autoimmune Diseases and Mental Health Challenges
A study presented at the Spanish Diabetes Society congress reveals that children with type 1 diabetes frequently develop other autoimmune diseases like celiac disease and thyroid disorders, significantly increasing the complexity of care and impacting mental health; interventions like summer camps a...
Progress
28% Bias Score


Single Genetic Variation Holds Key to Type 1 Diabetes Prevention and Treatment
Dutch researchers discovered a single genetic letter variation protecting against type 1 diabetes, affecting 100,000 people, enabling more precise diagnosis, prediction, and potential new treatments using CRISPR-Cas technology; the research is published in Cell.
Single Genetic Variation Holds Key to Type 1 Diabetes Prevention and Treatment
Dutch researchers discovered a single genetic letter variation protecting against type 1 diabetes, affecting 100,000 people, enabling more precise diagnosis, prediction, and potential new treatments using CRISPR-Cas technology; the research is published in Cell.
Progress
28% Bias Score


Inconsistent School Policies on Remote Monitoring of CGMs for Type 1 Diabetes
Continuous glucose monitors (CGMs) improve Type 1 diabetes management in schools, but inconsistent policies on remote monitoring by school staff due to staff shortages and technical issues leave many parents monitoring their children's blood sugar remotely, creating safety concerns that have led to ...
Inconsistent School Policies on Remote Monitoring of CGMs for Type 1 Diabetes
Continuous glucose monitors (CGMs) improve Type 1 diabetes management in schools, but inconsistent policies on remote monitoring by school staff due to staff shortages and technical issues leave many parents monitoring their children's blood sugar remotely, creating safety concerns that have led to ...
Progress
44% Bias Score

Sanofi's Tzield Approved in China for Type 1 Diabetes Prevention
Sanofi's Tzield, an injection delaying type 1 diabetes progression, received approval in China, offering a three-year delay to stage 3 for eligible patients, impacting 600,000 individuals.

Sanofi's Tzield Approved in China for Type 1 Diabetes Prevention
Sanofi's Tzield, an injection delaying type 1 diabetes progression, received approval in China, offering a three-year delay to stage 3 for eligible patients, impacting 600,000 individuals.
Progress
36% Bias Score

Mattel's New Barbie Doll Represents Children with Type 1 Diabetes
Mattel launched a Barbie doll with type 1 diabetes, featuring a continuous glucose monitor, insulin pump, and medical supplies, marking a significant step toward inclusivity in children's toys and normalizing the condition.

Mattel's New Barbie Doll Represents Children with Type 1 Diabetes
Mattel launched a Barbie doll with type 1 diabetes, featuring a continuous glucose monitor, insulin pump, and medical supplies, marking a significant step toward inclusivity in children's toys and normalizing the condition.
Progress
36% Bias Score

Diabetes Visibility: Challenges and Systemic Needs
Increased visibility of type 1 diabetes through social media influencers and public figures is challenging misconceptions and improving management, but systemic changes are needed to better support mental health needs, given the high prevalence of conditions like diabulimia, affecting 3 in 10 women ...

Diabetes Visibility: Challenges and Systemic Needs
Increased visibility of type 1 diabetes through social media influencers and public figures is challenging misconceptions and improving management, but systemic changes are needed to better support mental health needs, given the high prevalence of conditions like diabulimia, affecting 3 in 10 women ...
Progress
32% Bias Score

Single Genetic Variation Found to Protect Against Type 1 Diabetes
Dutch researchers discovered a single-letter genetic variation protecting against type 1 diabetes, affecting 100,000 people in the Netherlands; this discovery, published in Cell, enables more precise diagnoses, improved disease prediction, and potential new treatments.

Single Genetic Variation Found to Protect Against Type 1 Diabetes
Dutch researchers discovered a single-letter genetic variation protecting against type 1 diabetes, affecting 100,000 people in the Netherlands; this discovery, published in Cell, enables more precise diagnoses, improved disease prediction, and potential new treatments.
Progress
28% Bias Score

UK Study Tests At-Home Type 1 Diabetes Diagnosis Kit
A UK study is assessing the GTT@home test, a new home-based diagnostic kit for type 1 diabetes in children, involving 90 participants to evaluate its effectiveness compared to traditional methods and potential for NHS rollout; the test uses finger-prick blood samples and a glucose drink for at-home ...

UK Study Tests At-Home Type 1 Diabetes Diagnosis Kit
A UK study is assessing the GTT@home test, a new home-based diagnostic kit for type 1 diabetes in children, involving 90 participants to evaluate its effectiveness compared to traditional methods and potential for NHS rollout; the test uses finger-prick blood samples and a glucose drink for at-home ...
Progress
40% Bias Score

CAR T-Cell Therapy Shows Promise for Autoimmune Disease Cure
UK scientists are trialing CAR T-cell therapy—a cancer treatment—to cure autoimmune disorders like lupus, with early results showing potential for remission and prevention, although long-term effects are still unknown.

CAR T-Cell Therapy Shows Promise for Autoimmune Disease Cure
UK scientists are trialing CAR T-cell therapy—a cancer treatment—to cure autoimmune disorders like lupus, with early results showing potential for remission and prevention, although long-term effects are still unknown.
Progress
56% Bias Score
Showing 1 to 12 of 13 results